acth (4-10) has been researched along with leptin in 2 studies
| Studies (acth (4-10)) | Trials (acth (4-10)) | Recent Studies (post-2010) (acth (4-10)) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
|---|---|---|---|---|---|
| 187 | 15 | 3 | 25,940 | 1,628 | 11,468 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bickel, U; Born, J; Fehm, HL; Kern, W; McGregor, GP; Smolnik, R | 1 |
| Born, J; Fehm, HL; Hallschmid, M; McGregor, G; Smolnik, R | 1 |
2 trial(s) available for acth (4-10) and leptin
| Article | Year |
|---|---|
The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Adult; alpha-MSH; Body Composition; Humans; Insulin; Leptin; Melanocyte-Stimulating Hormones; Peptide Fragments; Placebos; Receptor, Melanocortin, Type 4; Receptors, Peptide; Thyroid Hormones; Thyrotropin; Weight Loss | 2001 |
Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.
Topics: Administration, Intranasal; Adrenocorticotropic Hormone; Adult; Body Composition; Body Weight; Double-Blind Method; Drug Resistance; Humans; Hydrocortisone; Insulin; Leptin; Male; Middle Aged; Overweight; Peptide Fragments | 2006 |